Arbutus Biopharma Corporation
(NASDAQ : ABUS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.28%89.781.3%$814.23m
AMGNAmgen Inc.
1.28%187.881.2%$637.06m
GILDGilead Sciences, Inc.
0.26%65.720.9%$483.54m
BIIBBiogen Inc.
0.74%323.561.3%$430.62m
ILMNIllumina, Inc.
1.60%301.633.5%$316.33m
REGNRegeneron Pharmaceuticals, Inc.
0.93%422.512.6%$292.88m
VRTXVertex Pharmaceuticals Incorporated
0.84%184.601.9%$255.72m
ALXNAlexion Pharmaceuticals, Inc.
0.89%128.692.0%$221.64m
SRPTSarepta Therapeutics, Inc.
1.21%138.1915.4%$154.17m
AAgilent Technologies, Inc.
0.13%77.991.6%$151.00m
EXASExact Sciences Corporation
7.63%89.6325.3%$142.36m
INCYIncyte Corporation
1.08%84.232.5%$113.14m
ARRYArray BioPharma Inc.
3.43%23.498.2%$111.72m
EXELExelixis, Inc.
0.80%21.396.4%$82.72m
NBIXNeurocrine Biosciences, Inc.
1.21%78.255.1%$78.16m

Company Profile

Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.